Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of LUM/IVA combination
therapy in subjects 12 years and older with CF and advanced lung disease and who are
homozygous for the F508del CFTR mutation